Suppr超能文献

抗菌剂与宿主防御

Antimicrobial agents and host defence.

作者信息

Forsgren A

出版信息

Scand J Infect Dis Suppl. 1984;43:24-33.

PMID:6598518
Abstract

Reports from different laboratories on effects of different antibiotics on host defence are often hard to compare because of differences in experimental design. The purpose of this presentation was to describe the effect of many different antibiotics with the same standardized techniques. E. coli and S. aureus pre-exposed to different beta-lactam antibiotics or gentamicin in subinhibitory concentrations were more susceptible to phagocytosis and killing by granulocytes than non-treated bacteria. A markedly depressed chemotaxis was detected when human leucocytes were incubated with fusidic acid and rifampicin in clinically obtainable concentration and well absorbed tetracyclines at high concentrations. The incorporation of 14C-leucine into a trichloracetic-acid insoluble form by human neutrophils was markedly depressed by the same antibiotics. Many other antibiotics did not inhibit granulocyte or lymphocyte functions. At therapeutic concentrations fusidic acid and rifampicin had a pronounced inhibition effect on the incorporation of 3H-thymidine by human T-lymphocytes stimulated by PHA and B-lymphocytes by S. aureus, Cowan I. At concentrations above the therapeutic level, inhibition was detected for doxycycline, erythromycin, clindamycin and nitrofurantoin. Due to high albumin binding for some of the tested antibiotics and other factors involved, experiments were performed to test whether depression also takes place in vivo. The cellular immunity in mice was registered by monitoring the survival of transplanted heart grafts. Rifampicin at human therapeutic dose had a strong inhibiting effect (p less than 0.001) on the rejection of heart grafts. The effect of doxycycline (2.5 mg/kg/day) and fusidic acid (25 mg/kg/day) was slight but significant (p less than 0.02).

摘要

由于实验设计的差异,不同实验室关于不同抗生素对宿主防御影响的报告往往难以比较。本报告的目的是用相同的标准化技术描述多种不同抗生素的作用。预先暴露于亚抑制浓度的不同β-内酰胺抗生素或庆大霉素的大肠杆菌和金黄色葡萄球菌,比未处理的细菌更容易被粒细胞吞噬和杀灭。当人类白细胞与临床可获得浓度的夫西地酸和利福平以及高浓度的吸收良好的四环素一起孵育时,检测到趋化性明显降低。相同的抗生素会显著抑制人类中性粒细胞将14C-亮氨酸掺入三氯乙酸不溶性形式。许多其他抗生素不会抑制粒细胞或淋巴细胞功能。在治疗浓度下,夫西地酸和利福平对PHA刺激的人类T淋巴细胞以及金黄色葡萄球菌Cowan I刺激的B淋巴细胞掺入3H-胸腺嘧啶核苷有明显的抑制作用。在高于治疗水平的浓度下,检测到强力霉素、红霉素、克林霉素和呋喃妥因有抑制作用。由于一些受试抗生素的高白蛋白结合率以及其他相关因素,进行了实验以测试体内是否也会发生抑制作用。通过监测移植心脏移植物的存活情况来记录小鼠的细胞免疫。人类治疗剂量的利福平对心脏移植物的排斥有强烈的抑制作用(p<0.001)。强力霉素(2.5mg/kg/天)和夫西地酸(25mg/kg/天)的作用轻微但显著(p<0.02)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验